SMTL ID : 4tor.6 (7 other biounits)

Crystal structure of Tankyrase 1 with IWR-8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

homo-dimer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 6 residues within 4Å: Chain A: C.155, T.157, H.158, C.163, I.165, C.166 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.155, A:H.158, A:C.163, A:C.166 ZN.9: 6 residues within 4Å: Chain B: C.155, T.157, H.158, C.163, I.165, C.166 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:C.155, B:H.158, B:C.163, B:C.166

2 x IW8: 1-[(1-acetyl-5-bromo-1H-indol-6-yl)sulfonyl]-N-ethyl-N-(3-methylphenyl)piperidine-4-carboxamide(Non-covalent)

IW8.2: 21 residues within 4Å: Chain A: H.105, S.107, P.108, F.109, A.112, I.113, K.116, G.117, F.118, D.119, H.122, A.123, G.132, I.133, Y.134, Y.145, G.148, I.149 Chain B: T.157, H.158, I.165 14 PLIP interactions: 2 interactions with chain B, 12 interactions with chain A Hydrophobic interactions: B:T.157, B:I.165, A:F.109, A:F.109, A:F.109, A:A.112, A:H.122, A:Y.134, A:I.149 Hydrogen bonds: A:D.119, A:Y.134 pi-Stacking: A:H.122, A:H.122 Halogen bonds: A:G.117 IW8.10: 21 residues within 4Å: Chain A: T.157, H.158, I.165 Chain B: H.105, S.107, P.108, F.109, A.112, I.113, K.116, G.117, F.118, D.119, H.122, A.123, G.132, I.133, Y.134, Y.145, G.148, I.149 14 PLIP interactions: 12 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:F.109, B:F.109, B:F.109, B:A.112, B:H.122, B:Y.134, B:I.149, A:T.157, A:I.165 Hydrogen bonds: B:D.119, B:Y.134 pi-Stacking: B:H.122, B:H.122 Halogen bonds: B:G.117

12 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 6 residues within 4Å: Chain A: A.112, H.115, K.116 Chain B: I.69, R.70, H.167 Ligand excluded by PLIP CL.4: 5 residues within 4Å: Chain A: V.75, N.76, K.77, R.80, Y.222 Ligand excluded by PLIP CL.5: 4 residues within 4Å: Chain A: H.53, R.54, A.209, Y.210 Ligand excluded by PLIP CL.6: 5 residues within 4Å: Chain A: P.108, F.109, N.111, A.112 Chain B: H.167 Ligand excluded by PLIP CL.7: 4 residues within 4Å: Chain A: H.191, A.192, Y.216, R.217 Ligand excluded by PLIP CL.8: 3 residues within 4Å: Chain A: H.97, H.98, N.99 Ligand excluded by PLIP CL.11: 6 residues within 4Å: Chain A: I.69, R.70, H.167 Chain B: A.112, H.115, K.116 Ligand excluded by PLIP CL.12: 5 residues within 4Å: Chain B: V.75, N.76, K.77, R.80, Y.222 Ligand excluded by PLIP CL.13: 4 residues within 4Å: Chain B: H.53, R.54, A.209, Y.210 Ligand excluded by PLIP CL.14: 5 residues within 4Å: Chain A: H.167 Chain B: P.108, F.109, N.111, A.112 Ligand excluded by PLIP CL.15: 4 residues within 4Å: Chain B: H.191, A.192, Y.216, R.217 Ligand excluded by PLIP CL.16: 3 residues within 4Å: Chain B: H.97, H.98, N.99 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kulak, O. et al., Disruption of Wnt/ beta-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells. Mol.Cell.Biol. (2015)

Release Date

2015-05-20

Peptides

Tankyrase-1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
B

Tankyrase-1

Related Entries With Identical Sequence